(Q42544602)

English

The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats

scientific article published on January 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

author name string

V Kayser

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

J J Idänpään-Hekkilä

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

D Christensen

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

G Guilbaud

4

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

947-952

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Pharmacology of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rats with a peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Behavioural evidence that systemic morphine may modulate a phasic pain-related behaviour in a rat model of peripheral mononeuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

The antinociceptive activity of kappa- but not delta-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Cholecystokinin and morphine analgesia: variations on a theme

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Ethical guidelines for investigations of experimental pain in conscious animals

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Repeated low doses of morphine induce a rapid tolerance in arthritic rats but a potentiation of opiate analgesia in normal animals

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Dependence in the absence of tolerance to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Morphine dependence with or without tolerance in formalin-treated mice: further evidence for the dissociation.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Anatomically distinct opiate receptor fields mediate reward and physical dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Neural substrates of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Effects of cholecystokinin receptor agonist and antagonists on morphine dependence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Identifiers

10.1016/S0024-3205(98)00012-5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42544602&oldid=1961288046"